Seeing Is Believing
CNTX is currently covered by 1 analysts with an average price target of $5.3. This is a potential upside of $3.89 (275.89%) from yesterday's end of day stock price of $1.41.
Context Therapeutics's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of CNTX is 80% BUY and 20% HOLD.
Highest price target for CNTX is $5, Lowest price target is $5, average price target is $5.3.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 01-Nov-2023. First documented stock forecast 02-Feb-2022.
Currently out of the existing stock ratings of CNTX, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$3.7 (284.62%)
5 months 25 days ago
0/4 (0%)
$3.89 (350.45%)
What is CNTX (Context Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CNTX (Context Therapeutics)?
Which analyst is the currently most bullish on CNTX (Context Therapeutics)?